An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
Marie C. Hasselluhn, Denise Schlösser, Lennart Versemann, G. Schmídt, Maria Ulisse, Joana Oschwald, Zhe Zhang, Feda H. Hamdan, Harry Xiao, Waltraut Kopp, Jessica Spitalieri, Christin Kellner, Carolin Schneider, K Reutlinger, Sankari Nagarajan, Benjamin Steuber, Stephen A. Sastra, Carmine F. Palermo, Jennifer Appelhans, Hanibal Bohnenberger, Jovan Todorović, Irina Kostyuchek, Philipp Ströbel, A Bockelmann, Alexander König, Christoph Ammer‐Herrmenau, Laura Schmidleitner, Silke Kaulfuß, Bernd Wollnik, Stephan A. Hahn, Albrecht Neeße, Shiv K. Singh, Holger Bastians, Maximilian Reichert, Ulrich Sax, Kenneth P. Olive, Steven A. Johnsen, Günter Schneider, Volker Ellenrieder, Elisabeth Heßmann
Topics & Concepts
GemcitabineCancer researchKRASPancreatic cancerBiologyTranscription factorProximity ligation assaySynthetic lethalityCancerGeneGeneticsDNA repairReceptorMutationSignaling Pathways in DiseaseTGF-β signaling in diseasesFOXO transcription factor regulation